Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura J Tafe

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Human Pathology|April 10, 2018
Somatic polymerase epsilon mutations as another route leading to loss of DNA MMR protein expression in endometrial carcinoma-replyLaura J Tafe
The Journal of Molecular Diagnostics : JMD|July 12, 2015
Targeted Next-Generation Sequencing for Hereditary Cancer Syndromes: A Focus on Lynch Syndrome and Associated Endometrial CancerLaura J Tafe
Advances in Anatomic Pathology|October 1, 2019
Non-Small Cell Lung Cancer as a Precision Oncology Paradigm: Emerging Targets and Tumor Mutational Burden (TMB)Laura J Tafe
Virchows Archiv : an International Journal of Pathology|March 11, 2017
Molecular mechanisms of therapy resistance in solid tumors: chasing "moving" targetsLaura J Tafe
Histopathology|July 14, 2018
Isocitrate dehydrogenase 1 mutations in melanoma frequently co-occur with NRAS mutationsKonstantinos Linos, Laura J Tafe
Experimental and Molecular Pathology|December 18, 2017
A case of a primary lung cancer comprised of adenocarcinoma and atypical carcinoid tumor with both components harboring BRAF p.V600E mutationAndrea M Olofson, Laura J Tafe
Clinical Chemistry and Laboratory Medicine|September 17, 2011
The human epidermal growth factor receptor 2 (HER2)Laura J Tafe, Gregory J Tsongalis
Clinical Chemistry|March 31, 2015
A 78-year-old woman with brain metastasesLaura J Tafe, Gregory J Tsongalis
Annals of Diagnostic Pathology|July 16, 2008
Cystic pancreatic schwannoma in a 46-year-old manLaura J Tafe, Arief A Suriawinata
The Urologic Clinics of North America|November 29, 2015
Emerging Bladder Cancer Biomarkers and Targets of TherapyGeorge J Netto, Laura J Tafe
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Human Pathology|April 10, 2018
Somatic polymerase epsilon mutations as another route leading to loss of DNA MMR protein expression in endometrial carcinoma-replyLaura J Tafe
The Journal of Molecular Diagnostics : JMD|July 12, 2015
Targeted Next-Generation Sequencing for Hereditary Cancer Syndromes: A Focus on Lynch Syndrome and Associated Endometrial CancerLaura J Tafe
Advances in Anatomic Pathology|October 1, 2019
Non-Small Cell Lung Cancer as a Precision Oncology Paradigm: Emerging Targets and Tumor Mutational Burden (TMB)Laura J Tafe
Virchows Archiv : an International Journal of Pathology|March 11, 2017
Molecular mechanisms of therapy resistance in solid tumors: chasing "moving" targetsLaura J Tafe
Histopathology|July 14, 2018
Isocitrate dehydrogenase 1 mutations in melanoma frequently co-occur with NRAS mutationsKonstantinos Linos, Laura J Tafe
Experimental and Molecular Pathology|December 18, 2017
A case of a primary lung cancer comprised of adenocarcinoma and atypical carcinoid tumor with both components harboring BRAF p.V600E mutationAndrea M Olofson, Laura J Tafe
Clinical Chemistry and Laboratory Medicine|September 17, 2011
The human epidermal growth factor receptor 2 (HER2)Laura J Tafe, Gregory J Tsongalis
Clinical Chemistry|March 31, 2015
A 78-year-old woman with brain metastasesLaura J Tafe, Gregory J Tsongalis
Annals of Diagnostic Pathology|July 16, 2008
Cystic pancreatic schwannoma in a 46-year-old manLaura J Tafe, Arief A Suriawinata
The Urologic Clinics of North America|November 29, 2015
Emerging Bladder Cancer Biomarkers and Targets of TherapyGeorge J Netto, Laura J Tafe
Pageof 11